Saturday, July 11, 2026

pharma · postmenopausal women with vasomotor menopausal symptoms

Estetra

Estetra SPRL is a pharma organization headquartered in EU. Primary therapeutic focus areas include postmenopausal women with vasomotor menopausal symptoms. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), a

Liège, BE HQ
30 Employees
EMA registrant Type
Company details
Status
Public
HQ
Liège, BE
Employees
30
Programs
1
Drugs
6
Patents
0
Clinical program

Film-coated placebo to match estetrol monohydrate (E4) 20mg tablet

Phase 2 · small molecule · postmenopausal women with vasomotor menopausal symptoms

Film-coated placebo to match estetrol monohydrate (E4) 20mg tablet for postmenopausal women with vasomotor menopausal symptoms is a Phase 2 program (small_molecule) at Estetra SPRL with 1 ClinicalTrials.gov record(s).

← All Estetra SPRL projects Phase 2 small molecule active

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Estetra SPRL
Phase
Phase 2
Modality
small_molecule
Indication
postmenopausal women with vasomotor menopausal symptoms
Status
active
Trials
1